These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6593700)

  • 21. Assessing Symptom Burden in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Patients.
    Garza J; Anderson JM; Scherber RM
    Hematol Oncol Clin North Am; 2020 Apr; 34(2):475-489. PubMed ID: 32089224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
    Tovar-Bobadilla JL; Ortiz-Hidalgo C
    Gac Med Mex; 2016; 152(3):407-18. PubMed ID: 27335198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chromosome findings in myeloproliferative diseases].
    Hellriegel KP
    Internist (Berl); 1968 Dec; 9(12):465-70. PubMed ID: 4891471
    [No Abstract]   [Full Text] [Related]  

  • 24. Ph-positive and -negative myeloproliferative syndromes may co-exist.
    Mauro MJ; Loriaux M; Deininger MW
    Leukemia; 2004 Jul; 18(7):1305-7. PubMed ID: 15103389
    [No Abstract]   [Full Text] [Related]  

  • 25. Classification of chronic myeloproliferative diseases by bone marrow biopsies. Hematological and cytogenetic findings and clinical course.
    Georgii A; Vykoupil KF; Thiele J
    Bibl Haematol; 1984; (50):41-56. PubMed ID: 6590038
    [No Abstract]   [Full Text] [Related]  

  • 26. Transient myeloproliferative disorder and acute myeloid leukemia: study of six neonatal cases with long-term follow-up.
    Liang DC; Ma SW; Lu TH; Lin ST
    Leukemia; 1993 Oct; 7(10):1521-4. PubMed ID: 8412314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy].
    Matolcsy A; Kónya T; Wéber E
    Orv Hetil; 1992 Jun; 133(26):1617-20, 1625-6. PubMed ID: 1614699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differential diagnostic significance of the Ph chromosome].
    Hampel KE
    Verh Dtsch Ges Inn Med; 1967; 73():457-60. PubMed ID: 5242223
    [No Abstract]   [Full Text] [Related]  

  • 29. [Myeloproliferative masks of multiple myeloma: A review of literature and clinical case reports].
    Ryzhko VV; Grachev AE; Klodzinsky AA; Ivanova TV; Sataeva MS; Gribanova EO
    Ter Arkh; 2017; 89(1):72-77. PubMed ID: 28252631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pure red-cell aplasia associated with chronic myeloproliferative syndromes].
    Villarrubia J; Pascual C; Pérez Vaquero MA; Escribano L; Bellas C; Orte J; Heinrichs B; Velasco JL
    Med Clin (Barc); 1992 Feb; 98(4):139-41. PubMed ID: 1552765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytogenetic studies in Philadelphia chromosome-negative myeloproliferative disorders, particularly polycythaemia rubra vera.
    Lawler SD
    Clin Haematol; 1980 Feb; 9(1):159-74. PubMed ID: 6768481
    [No Abstract]   [Full Text] [Related]  

  • 32. Atypical myeloproliferative disorders: diagnosis and management.
    Tefferi A; Elliott MA; Pardanani A
    Mayo Clin Proc; 2006 Apr; 81(4):553-63. PubMed ID: 16610578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders.
    Lichtman MA
    Leukemia; 2005 Jul; 19(7):1139-41. PubMed ID: 15902283
    [No Abstract]   [Full Text] [Related]  

  • 34. [Significance of cytogenetic methods in the diagnosis and differential diagnosis of myeloproliferative diseases (review of the literature and personal data)].
    Fleĭshman EV; Volkova MA
    Probl Gematol Pereliv Krovi; 1970 Aug; 15(8):53-8. PubMed ID: 4935743
    [No Abstract]   [Full Text] [Related]  

  • 35. Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours.
    Abukhiran IA; Jasser J; Syrbu S
    J Clin Pathol; 2020 Jun; 73(6):310-313. PubMed ID: 31941653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
    Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A "myeloproliferative syndrome" of long duration (author's transl)].
    Kühböck J; Peskar BM; Vormittag W
    Med Klin; 1974 Mar; 69(10):423-6. PubMed ID: 4524608
    [No Abstract]   [Full Text] [Related]  

  • 38. Myelogenous leukemia and related myeloproliferative disorders in beagles continuously exposed to 60Co gamma-radiation.
    Fritz TE; Norris WP; Tolle DV
    Bibl Haematol; 1973; 39():170-88. PubMed ID: 4521521
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical pathological features of the 8p11 myeloproliferative syndrome].
    Yan Z; Yang B; Wang QS; Wang LL; Han XP; Ren F; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1321-6. PubMed ID: 21129285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some uses of the continuous flow blood separator in the myeloproliferative syndrome.
    Bell R; Sullivan JR; Hurley TH; D'Apice AJ; Kincaid-Smith P
    Aust N Z J Med; 1978 Aug; 8(4):433-5. PubMed ID: 282861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.